Although further research is needed to clarify the molecular mechanisms underlying the protective role of SIRT1 in DMD, we propose SIRT1 as a novel hypothetical therapeutic target for patients with muscular dystrophies. This evidence concerns the gene SIRT1 and Duchenne muscular dystrophy.